510(k) device
Neurosoft TMS (also CloudTMS)
Teleemg, LLC · Transcranial Magnetic Stimulator (OBP, Class II) · First FDA decision Dec 22, 2016, newest Dec 13, 2017DepressionOCD, PTSD and other psychiatric conditions
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
10
Naming "Neurosoft TMS"
MAUDE reports
1
Brand "Neurosoft TMS", since 2015
PubMed studies
0
Mentioning "Neurosoft TMS"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Neurosoft TMS (also CloudTMS)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
K173441 · Decided Dec 13, 2017 · 37 days after receipt
Device type: Transcranial Magnetic Stimulator (OBP) · Neurology & Neurosurgery
- Neurosoft TMS510(k)
K160309 · Decided Dec 22, 2016 · 322 days after receipt
Device type: Transcranial Magnetic Stimulator (OBP) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Transcranial Magnetic StimulationLocal determinationIn effectL33398Wellpoint FederalUpdated Jul 16, 2026
- Transcranial Magnetic StimulationProposed local determinationProposedDL33398National Government Services, Inc.Updated Mar 27, 2026
- Transcranial Magnetic Stimulation (TMS)Local determinationIn effectL34641WPS Insurance CorporationUpdated Mar 20, 2026
- Transcranial Magnetic Stimulation (TMS)Local determinationIn effectL37086Noridian Healthcare Solutions, LLCUpdated Aug 6, 2025
- Repetitive Transcranial Magnetic Stimulation (rTMS) in AdultsLocal determinationIn effectL34869Palmetto GBAUpdated Jan 7, 2025
- Transcranial Magnetic Stimulation (TMS)Local determinationIn effectL36469CGS Administrators, LLCUpdated May 30, 2024
- Transcranial Magnetic Stimulation (TMS) in the Treatment of Adults with Major Depressive DisorderLocal determinationIn effectL34522First Coast Service Options, Inc.Updated Oct 21, 2022
- Transcranial Magnetic Stimulation (TMS) in the Treatment of Adults with Major Depressive DisorderLocal determinationIn effectL34998Novitas Solutions, Inc.Updated Oct 21, 2022
Clinical trials
Device studies on ClinicalTrials.gov that name "Neurosoft TMS", any status and sponsor, newest update first.
- Intermittent Theta-Burst Stimulation for Lower-Limb Spasticity and Pain in Multiple SclerosisNot yet recruiting
Comenius UniversityAcademic, hospital or other
NCT07786506 · 40 participants (planned) · Start Aug 10, 2026 · Primary completion Oct 31, 2026
Device: Active Intermittent Theta-Burst Stimulation (iTBS); Sham Intermittent Theta-Burst Stimulation · For: Multiple Sclerosis; Muscle Spasticity; Neuropathic Pain
Sites: Bratislava, Slovakia
Izmir Katip Celebi UniversityAcademic, hospital or other
NCT05505201 · 6 participants · Start Nov 11, 2022 · Primary completion May 28, 2025
Device: Repetitive transcranial magnetic stimulation; Sham Repetitive transcranial magnetic stimulation · For: Stroke Rehabilitation
Sites: Izmir, Turkey (Türkiye)
Izmir Katip Celebi UniversityAcademic, hospital or other
NCT06746922 · 30 participants (planned) · Start Mar 13, 2025 · Primary completion Feb 1, 2027
Device: Intermittent theta-burst stimulation; Sham Intermittent theta-burst stimulation · For: Fibromyalgia; Transcranial Magnetic Stimulation Repetitive; Pain
Sites: Izmir, Turkey (Türkiye)
- The Effectiveness of Repetitive Transcranial Magnetic Stimulation for Spastic Diplegia Cerebral PalsyStatus unknown
Universitat de LleidaAcademic, hospital or other
NCT05198921 · 30 participants (planned) · Start Jan 2025 · Primary completion May 2025
Device: repetitive Transcranial Magnetic Stimulation; sham repetitive Transcranial Magnetic Stimulation · For: Cerebral Palsy, Spastic
Sites: Lleida, Spain
Izmir Katip Celebi UniversityAcademic, hospital or other
NCT05601921 · 18 participants · Start Oct 1, 2022 · Primary completion Jul 14, 2023
Device: Repetitive transcranial magnetic stimulation; Sham Repetitive transcranial magnetic stimulation · For: Post-stroke Shoulder Pain
Sites: Izmir, Turkey (Türkiye)
- Quantitative EEG Changes Following Repetitive Transcranial Magnetic Stimulation in Patients With Post Stroke (EEG-rTMS)Status unknown
Izmir Katip Celebi UniversityAcademic, hospital or other
NCT05657392 · 50 participants (planned) · Start Apr 15, 2021 · Primary completion Oct 15, 2023
Device: repetitive Transcranial Magnetic Stimulation (rTMS) · For: Stroke; Stroke, Ischemic; Stroke/Brain Attack
Sites: Izmir, Turkey (Türkiye)
Izmir Katip Celebi UniversityAcademic, hospital or other
NCT04063995 · 37 participants · Start Sep 9, 2019 · Primary completion Jun 27, 2021
Device: Repetitive transcranial magnetic stimulation · For: Spasticity as Sequela of Stroke
Sites: Izmir, Turkey (Türkiye)
Federal University of São PauloAcademic, hospital or other
NCT02180984 · 95 participants · Start Nov 2015 · Primary completion Mar 2020
Device: TMS · For: Binge Eating; Obesity
Sites: São Paulo, Brazil
Universidade Federal de PernambucoAcademic, hospital or other
NCT02286349 · 12 participants · Start Sep 2014 · Primary completion Aug 2015
Device: Transcranial magnetic stimulation (Neurosoft®); Transcranial direct current stimulation (Soterix, USA) · For: Attention Deficit/Hyperactivity Disorder
- Efficacy Study of Transcranial Magnetic Stimulation for Treatment of Obsessive-Compulsive DisorderCompleted
University of BrasiliaAcademic, hospital or other
NCT01540305 · 22 participants · Start May 2011 · Primary completion Sep 2011
Device: Repetitive Transcranial Magnetic Stimulation (rTMS); Sham repetitive transcranial magnetic stimulation · For: Obsessive Compulsive Disorder
Sites: Brasília, Brazil
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Neurosoft TMS", and for the whole product code for context.
This brand
1 reports: 0 malfunction, 1 injury, 0 death
Whole product code OBP
337 reports: 9 malfunction, 323 injury, 2 death
Newest reports for this brand
- NEUROSOFT TMSInjury
MW5110884 · Received Jul 14, 2022 · Event dated Jul 7, 2022
Device type: Transcranial Magnetic Stimulator (OBP)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Tinnitus
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Neurosoft TMS"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code OBP.
- NeuroStar TMS Therapy SystemNeuronetics, Inc. · 510(k) 2022
- BrainsWay Deep TMS SystemBrainsway , Ltd. · 510(k) 2025
- Apollo TMS Therapy SystemMag & More GmbH · 510(k) 2026
- MagVita TMS Therapy w/MagPro R20Tonica Elektronik A/S · 510(k) 2017
- NeuroStar Advanced Therapy System (All previously cleared models)Neuronetics, Inc. · 510(k) 2024
- Magstim Horizon 3.0 TMS Therapy SystemMagstim Company, Ltd. · 510(k) 2023
- HORIZON TMS Therapy System with NavigationMagstim Company, Ltd. · 510(k) 2019
- Nexstim Navigated Brain Stimulation (NBS) 6 System (NBS6)Nexstim Oyj · 510(k) 2026
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.